House Republicans have abandoned language to rein in the pharmacy benefit manager (PBM) industry from a new government funding bill released late Thursday. Leaders earlier this week agreed to PBM ...

Currently, PBMs frequently retain a percentage of rebates paid to them by pharmaceutical companies in return for placing their drugs on the PBM’s formulary. The higher the list price of a drug ...

WASHINGTON — House Republicans have abandoned an effort to include reforms to pharmacy benefit managers in an end-of-year bill to fund the federal government. Congressional leaders had reached ...

Lawmakers agreed to extend telehealth flexibilities, fund public health programs, and enact these major PBM changes as part of a government funding package they are planning to pass before the end ...

For newer coverage of the American Relief Act, 2025 package, see President signs anti-shutdown package, with no PBM provisions. A big, "must pass" House package that included new rules for ...

However, it’s likely PBM reform will be resuscitated in Congress next year too, given Trump has expressed an interest in reining in PBMs. As for telehealth, Congress including a three-month ...

The PBM changes would put guardrails on the business practices of the industry, something that’s been a bipartisan priority for years but, until now, never made it to the finish. The package ...

“From our inception, we always believed that a transparent approach where we were paid to administer and then had some compensation transparently based on performance was a better approach.

The final text saw a number of legislative proposals culled in order to get it over the line, including measures that would have introduced stricter controls over the PBM sector that had been ...

Chevrolet Performance offers enthusiasts and builders an extensive catalogue of performance products and services, with the new website design aimed at streamlining the overall user experience.

The price at which the PBM obtains the drug for its clients is ... When PBMs favor their in-house products in formularies, this reduces the incentive for other drugmakers to introduce competing ...

US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' U.S. futures declined on Friday, ahead of the 'Triple ...